105 related articles for article (PubMed ID: 38825162)
1. Exosome-based anticancer vaccines: From Bench to bedside.
Zhao G; Wang Y; Xing S; Jiang Y; Ding J; Cai Y; Ma P; Miao H; Fang Y; Jiang N; Cui D; Yu Y; Tang Q; Wang S; Li N
Cancer Lett; 2024 Jul; 595():216989. PubMed ID: 38825162
[TBL] [Abstract][Full Text] [Related]
2. Exosome-based immunotherapy: a promising approach for cancer treatment.
Xu Z; Zeng S; Gong Z; Yan Y
Mol Cancer; 2020 Nov; 19(1):160. PubMed ID: 33183286
[TBL] [Abstract][Full Text] [Related]
3. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
Tian X; Zhu M; Nie G
Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
[TBL] [Abstract][Full Text] [Related]
4. Designer exosomes as next-generation cancer immunotherapy.
Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ
Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
Srivastava A; Rathore S; Munshi A; Ramesh R
AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
[TBL] [Abstract][Full Text] [Related]
6. Biology and function of exosomes in tumor immunotherapy.
Liu C; Xia C; Xia C
Biomed Pharmacother; 2023 Dec; 169():115853. PubMed ID: 37951023
[TBL] [Abstract][Full Text] [Related]
7. Exosomes-Small Players, Big Sound.
Gulei D; Irimie AI; Cojocneanu-Petric R; Schultze JL; Berindan-Neagoe I
Bioconjug Chem; 2018 Mar; 29(3):635-648. PubMed ID: 29369619
[TBL] [Abstract][Full Text] [Related]
8. Exosome-Based Vaccines: History, Current State, and Clinical Trials.
Santos P; Almeida F
Front Immunol; 2021; 12():711565. PubMed ID: 34335627
[TBL] [Abstract][Full Text] [Related]
9. The function and clinical application of extracellular vesicles in innate immune regulation.
Zhou X; Xie F; Wang L; Zhang L; Zhang S; Fang M; Zhou F
Cell Mol Immunol; 2020 Apr; 17(4):323-334. PubMed ID: 32203193
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-derived exosome (DEX) therapy for digestive system cancers: Recent advances and future prospect.
Al-Hawary SIS; Almajidi YQ; Bansal P; Ahmad I; Kaur H; Hjazi A; Deorari M; Zwamel AH; Hamzah HF; Mohammed BA
Pathol Res Pract; 2024 May; 257():155288. PubMed ID: 38653088
[TBL] [Abstract][Full Text] [Related]
11. Exosomes: Powerful weapon for cancer nano-immunoengineering.
Pi YN; Xia BR; Jin MZ; Jin WL; Lou G
Biochem Pharmacol; 2021 Apr; 186():114487. PubMed ID: 33647264
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of exosomes for cancer research.
Zhu L; Sun HT; Wang S; Huang SL; Zheng Y; Wang CQ; Hu BY; Qin W; Zou TT; Fu Y; Shen XT; Zhu WW; Geng Y; Lu L; Jia HL; Qin LX; Dong QZ
J Hematol Oncol; 2020 Nov; 13(1):152. PubMed ID: 33168028
[TBL] [Abstract][Full Text] [Related]
13. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
[TBL] [Abstract][Full Text] [Related]
14. Emerging innovations on exosome-based onco-therapeutics.
Dai X; Ye Y; He F
Front Immunol; 2022; 13():865245. PubMed ID: 36119094
[TBL] [Abstract][Full Text] [Related]
15. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
16. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Syn NL; Wang L; Chow EK; Lim CT; Goh BC
Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
[TBL] [Abstract][Full Text] [Related]
17. Roles of exosomes in immunotherapy for solid cancers.
Lyu C; Sun H; Sun Z; Liu Y; Wang Q
Cell Death Dis; 2024 Feb; 15(2):106. PubMed ID: 38302430
[TBL] [Abstract][Full Text] [Related]
18. Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.
Rountree RB; Mandl SJ; Nachtwey JM; Dalpozzo K; Do L; Lombardo JR; Schoonmaker PL; Brinkmann K; Dirmeier U; Laus R; Delcayre A
Cancer Res; 2011 Aug; 71(15):5235-44. PubMed ID: 21670078
[TBL] [Abstract][Full Text] [Related]
19. Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor.
Wang C; Huang X; Wu Y; Wang J; Li F; Guo G
Int J Biol Sci; 2020; 16(4):633-643. PubMed ID: 32025211
[TBL] [Abstract][Full Text] [Related]
20. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
